Artiva Biotherapeutics

98 employees

Biotech/Pharma

Public · $498.0M

Company details

Team Size98

IndustryBiotech/Pharma

Funding

Total raised

$498.0M

Last stage

Public

Investors

Venrock Healthcare Capital Partners

RA Capital Management

RTW Investments

StandoutYBacked by Y Combinator · P26

“LeBron has an agent. Why don’t you?”

— Now you have one too.

Earn $3,000

ProductHow it works For talent For companies Browse jobs Browse companies

CompanyAbout Blog Careers

ConnectTwitter / X LinkedIn

Standout.

Privacy Terms

Artiva Biotherapeutics | Biotech/Pharma | Standout | Standout

EcoR1 Capital

GC Cell

Founders

Tom Farrell

Co-founder of Artiva Biotherapeutics, listed on Crunchbase as one of the two founders of the company.

Fred Aslan

Joined Artiva as CEO in January 2021 and led the Series B financing and IPO. Previously President and CBO at Vividion Therapeutics (acquired by Bayer) and had a 12-year affiliation with Venrock.

Peter Flynn

Co-founder of Artiva Biotherapeutics with 22+ years of biotech experience. Former EVP at Orexigen Therapeutics and SVP of Early Program Development at Fate Therapeutics. Holds a PhD in Molecular Biology from UCL.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.